Compare TNGX & HGTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TNGX | HGTY |
|---|---|---|
| Founded | 2014 | 1984 |
| Country | United States | United States |
| Employees | 155 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.3B |
| IPO Year | N/A | N/A |
| Metric | TNGX | HGTY |
|---|---|---|
| Price | $10.77 | $13.41 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 7 | 7 |
| Target Price | $12.00 | ★ $13.83 |
| AVG Volume (30 Days) | ★ 3.1M | 156.3K |
| Earning Date | 11-04-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 241.11 |
| EPS | N/A | ★ 0.36 |
| Revenue | $66,501,000.00 | ★ $1,360,017,000.00 |
| Revenue This Year | $20.41 | $16.08 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $37.10 |
| Revenue Growth | ★ 53.29 | 17.92 |
| 52 Week Low | $1.03 | $8.03 |
| 52 Week High | $11.20 | $13.86 |
| Indicator | TNGX | HGTY |
|---|---|---|
| Relative Strength Index (RSI) | 74.54 | 63.18 |
| Support Level | $9.90 | $13.10 |
| Resistance Level | $11.20 | $13.60 |
| Average True Range (ATR) | 0.72 | 0.43 |
| MACD | 0.31 | 0.00 |
| Stochastic Oscillator | 89.35 | 67.92 |
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
Hagerty Inc is a provider of specialty automotive insurance. The company underwrites, sells, and services classic car and enthusiast vehicle insurance policies. Substantial revenue is derived from Commission and fees. Geographically it serves Europe, Canada, and the United States.